What Happens If The Japanese Designated Marketing Authorization Holder’s Company Structure Changes?

If the Japanese Designated Marketing Authorization Holder’s company structure changes, they must notify the Pharmaceuticals and Medical Devices Agency (PMDA) promptly. This includes mergers, acquisitions, or significant internal restructuring. The PMDA will assess the impact on compliance and product safety, potentially requiring updated documentation or re-evaluation of the marketing authorization.

Leave a Reply

You must be logged in to post a comment.